A pharmaceutical composition for the prevention and treatment of mental disorders, behavioral disorders and cognitive disorders

摘要

The present invention relates to the fields of medicine and pharmaceutical-chemical industry, in particular to the field of neurology, and relates to new compositions containing memantine and melatonin. It has been established that the enhancement of memantine effect occurs when combined with melatonin. The present invention can be realized through the preparation of final pharmaceutical products such as capsules, preferably hard gelatin capsules. [Selection figure] None